Biohaven Pharma (BHVN), Royalty Pharma (RPRX) Announce Funding Agreement Totaling up to $450 Million
Go back to Biohaven Pharma (BHVN), Royalty Pharma (RPRX) Announce Funding Agreement Totaling up to $450 Million| (NYSE: BHVN) | Delayed: 14.78 -0.72 (4.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.50 | 52 Week High | $ | |||
| Open | $15.04 | 52 Week Low | $ | |||
| Day High | $15.80 | P/E | N/A | |||
| Day Low | $14.75 | EPS | $ | |||
| Volume | 2,488,289 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 55.35 +1.78 (3.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.57 | 52 Week High | $3.48 | |||
| Open | $53.58 | 52 Week Low | $0.80 | |||
| Day High | $55.50 | P/E | N/A | |||
| Day Low | $53.31 | EPS | $-1.54 | |||
| Volume | 4,896,198 | |||||

